Drugs News and Research

RSS

3D-printed liver model paves way for new MASH treatments

Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD).

23 Jan 2024

New technique helps track the brain's "off switches"

For decades, scientists have studied the intricate activity patterns in human and animal brains by observing when different groups of brain cells turn on.

23 Jan 2024

Blood pressure drug could help lower anxiety for kids and young adults with ASD

A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD).

23 Jan 2024

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet in Sweden published in the journal Gut.

23 Jan 2024

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

23 Jan 2024

NIH grant funds the development of allograft-rejection-on-a-chip model

Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop a functional organ-on-a-chip to model allogeneic transplant rejection.

23 Jan 2024

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

A novel rabbit infection model to investigate meropenem's resistance development.

23 Jan 2024

The long-term outcomes of diabetes remission and its impact on health

Researchers examine the effect of diabetes remission on long-term health outcomes.

23 Jan 2024

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Diet modification and alterations in the intestinal microbial population could impact the disease course of Alzheimer’s and Parkinson’s diseases.

23 Jan 2024

Study finds no fertility decline in men with inflammatory joint disease

Men with inflammatory joint disease, such as rheumatoid arthritis, are less likely to be childless and have more children than their healthy peers, suggests research published online in the Annals of the Rheumatic Diseases.

22 Jan 2024

Study identifies genetic variants that influence response to preterm birth treatment

A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.

22 Jan 2024

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.

22 Jan 2024

New study unlocks secrets to preventing birth defects

Cleft lip and palate are the most common craniofacial birth defects in humans, affecting more than 175,000 newborns around the world each year.

22 Jan 2024

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Researchers performed a meta-analysis of randomized trial studies that compared the use of amyloid-reducing monoclonal antibodies (MABs) in patients with Alzheimer's dementia at a dose consistent with that used in Phase 3 or FDA approval trials with the use of a placebo.

22 Jan 2024

Revolutionary bio-sponge halts bleeding instantly

More than 11 million people in the United States take anticoagulation or antiplatelet medications, such as heparin or aspirin, to treat serious conditions like heart attack and stroke.

22 Jan 2024

Patient-specific "organ-on-chip" aims to accelerate research on cholangiocarcinoma

It is only a few centimeters in size and can be held between two fingers, but in the micro-channels carved inside it, it's hidden a three-dimensional and highly faithful model of a biliary tract cancer called cholangiocarcinoma, complete with its tumor microenvironment.

22 Jan 2024

Drugs News and Research

3D-printed liver model paves way for new MASH treatments

New technique helps track the brain's "off switches"

Blood pressure drug could help lower anxiety for kids and young adults with ASD

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

NIH grant funds the development of allograft-rejection-on-a-chip model

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

The long-term outcomes of diabetes remission and its impact on health

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Study finds no fertility decline in men with inflammatory joint disease

Study identifies genetic variants that influence response to preterm birth treatment

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

New study unlocks secrets to preventing birth defects

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Revolutionary bio-sponge halts bleeding instantly

Patient-specific "organ-on-chip" aims to accelerate research on cholangiocarcinoma

Moffitt researchers develop novel reagent for efficient synthesis of sulfur-containing drug candidates

Cancer drug holds promise for shrinking polycystic kidney cysts

Receptor protein found to be a key player in prostate cancer cells' drug resistance

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News